Last reviewed · How we verify
NCT06591988: ZEPHYR
Environmental Pollutants and Life Quality
trial testing Lifestyle factors in Environment in 608 participants. Enrolling by invitation.
1 April 2025
Quick facts
| Lead sponsor | Azienda Sanitaria Locale di Taranto |
|---|---|
| Status | ENROLLING BY INVITATION |
| Study type | OBSERVATIONAL |
| Enrollment | 608 |
| Start date | 1 September 2024 |
| Primary completion | 1 April 2025 |
| Estimated completion | 1 October 2025 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Lifestyle factors
Conditions studied
- Environment — all drugs for Environment →
- Pollution Exposure — all drugs for Pollution Exposure →
- Mortality — all drugs for Mortality →
- Healthcare — all drugs for Healthcare →
Sponsor
Azienda Sanitaria Locale di Taranto
Who can join
Eligibility, any sex, with Environment or Pollution Exposure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is part of the MISTRAL project, funded by the European Commission under the Horizon Europe Program, within the Work Programme 2021-2022 of Pillar II - Health Cluster on Environment and Health, which has the main objective of creating a cloud-based informatics platform for Health Impact Assessment analysis that, thanks to artificial intelligence, is able to simulate different clinical scenarios, economic and social, before and after the introduction of environmental risk mitigation policies, starting from data and evidence derived from case studies (several European cities) with different levels of exposure to environmental, health, geographical and socio-economic factors. The Project involves 11 partners distributed among Italy (Istituto Superiore di Sanità, Azienda Sanitaria Locale di Taranto, University of Bari, Politecnico di Bari, APS PLANET), Belgium (University of Hasselt), Poland (AGH-University of Technology and Science), Germany (Nuromedia), Spain (Ubitel), Greece (WINGS-ICT Solutions) and England (University of Oxford, University of Suffolk). Specifically, the ZEPHYR study is a cross-sectional (cross-sectional), population-based, multicenter survey. The centers involved are the ASL of Taranto with the Taranto City Single District (Coordinating Recruitment Center), the University of Hasselt, Belgium (Recruitment Center Hasselt Hospital Campus), and the University of Krakow, Poland (Rybnik University Hospital as recruitment center).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06591988
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Environment
Currently open trials in the same condition.
- NCT05350761 — Rare Tumors and Cancer Predisposition in Individuals and Families · recruiting
- NCT00001163 — Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06591988 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Azienda Sanitaria Locale di Taranto
- Last refreshed: 19 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06591988.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing